BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 24616192)

  • 1. New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligands.
    Orbisaglia S; Di Nicola C; Marchetti F; Pettinari C; Pettinari R; Martins LM; Alegria EC; da Silva MF; Rocha BG; Kuznetsov ML; Pombeiro AJ; Skelton BW; Sobolev AN; White AH
    Chemistry; 2014 Mar; 20(13):3689-704. PubMed ID: 24616192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands.
    Marchetti F; Pettinari C; Cerquetella A; Cingolani A; Pettinari R; Monari M; Wanke R; Kuznetsov ML; Pombeiro AJ
    Inorg Chem; 2009 Jul; 48(13):6096-108. PubMed ID: 19507885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
    Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New bis-, tris- and tetrakis(pyrazolyl)borate ligands with 3-pyridyl and 4-pyridyl substituents: synthesis and coordination chemistry.
    Adams H; Batten SR; Davies GM; Duriska MB; Jeffery JC; Jensen P; Lu J; Motson GR; Coles SJ; Hursthouse MB; Ward MD
    Dalton Trans; 2005 Jun; (11):1910-23. PubMed ID: 15909037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
    Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
    Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
    Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
    Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-pot synthesis of symmetric and asymmetric p-quinone ligands and unprecedented substituent induced reactivity in their dinuclear ruthenium complexes.
    Schweinfurth D; Das HS; Weisser F; Bubrin D; Sarkar B
    Inorg Chem; 2011 Feb; 50(3):1150-9. PubMed ID: 21214266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strong-field tripodal phosphine donor, [PhB(CH2PiPr2)3]-, provides access to electronically and coordinatively unsaturated transition metal complexes.
    Betley TA; Peters JC
    Inorg Chem; 2003 Aug; 42(17):5074-84. PubMed ID: 12924878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetrical diruthenium complex bridged by a redox-active ligand.
    Das A; Scherer TM; Chowdhury AD; Mobin SM; Kaim W; Lahiri GK
    Inorg Chem; 2012 Feb; 51(3):1675-84. PubMed ID: 22251030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state (15)N CPMAS NMR and computational analysis of ligand hapticity in rhodium(η-diene) poly(pyrazolyl)borate complexes.
    Pettinari R; Pettinari C; Marchetti F; Gobetto R; Nervi C; Chierotti MR; Chan EJ; Skelton BW; White AH
    Inorg Chem; 2010 Dec; 49(23):11205-15. PubMed ID: 20979369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time.
    Rafols L; Josa D; Aguilà D; Barrios LA; Roubeau O; Cirera J; Soto-Cerrato V; Pérez-Tomás R; Martínez M; Grabulosa A; Gamez P
    Inorg Chem; 2021 Jun; 60(11):7974-7990. PubMed ID: 33979132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
    Yadav M; Singh AK; Maiti B; Pandey DS
    Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylcyanamidoruthenium scorpionate complexes.
    Harb C; Kravtsov P; Choudhuri M; Sirianni ER; Yap GP; Lever AB; Crutchley RJ
    Inorg Chem; 2013 Feb; 52(3):1621-30. PubMed ID: 23339541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazoalkane complexes of ruthenium with tris(pyrazolyl)borate and bis(pyrazolyl)acetate ligands.
    Albertin G; Antoniutti S; Bortoluzzi M; Castro J; Marzaro L
    Dalton Trans; 2015 Sep; 44(35):15470-80. PubMed ID: 26237267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterisation and antibacterial activity of [(p-cym)RuX(L)](+/2+) (X = Cl, H2O; L = bpmo, bpms) complexes.
    Tripathy SK; Taviti AC; Dehury N; Sahoo A; Pal S; Beuria TK; Patra S
    Dalton Trans; 2015 Mar; 44(11):5114-24. PubMed ID: 25675378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New homodinuclear tris(3-alkylpyrazolyl)borate complexes of Co
    Mikhalyova EA; Trofimenko S; Zeller M; Addison AW; Pavlishchuk VV
    Acta Crystallogr C Struct Chem; 2016 Nov; 72(Pt 11):777-785. PubMed ID: 27811411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.